tirzepatide from empower pharmacy It's officially TIRZ-day! ODT is our new, orange-flavored, injection-free GLP-1 option for needle-nervous patients. Go to the link in bio to find out more. #Tirzepatide #ODT #WeightManagement #EmpowerPharmacy #CompoundingisPersonal Addressing the Weight Loss Injectable

We are committed to helping our patients achieve and maintain a healthy weight as part of total wellness

Refer to our article on what happens if tirzepatide gets warm if you suspect your vial has been temperature-compromised, or check whether your compounded tirzepatide has passed its expiration date

Semaglutide is the same active ingredient used in three products marketed by Novo Nordisk: Ozempic, Rybelsus, and Wegovy

The results of the injection may vary depending on the individual patient, but most patients experience significant weight loss and improved blood sugar control within a few weeks of treatment

Medicare Part D does not cover GLP-1 medications for weight loss (only for diabetes with an A1C 6.5%), and most commercial insurance plans either exclude weight loss medications entirely or require prior authorisation with BMI 35 plus two comorbidities

A dosage chart for Tirzepatide generally outlines a progressive increase in dosage from as low as 2.5 mg per week to as much as 15 mg per week over several months